Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Clinical trial NCT00226408 · UNKNOWN

Trial details

NCT number: NCT00226408
Sponsor: Dermatologic Cooperative Oncology Group
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Adjuvant Stage III Malignant Melanoma Interferon Alpha Therapy

Start date: 2003-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.